# Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

> **NCT00793195** · PHASE2 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 24 (estimated)

## Conditions studied

- Short Bowel Syndrome
- Intestinal Failure
- Gastrointestinal Motility Disorder
- Mucosal Enteropathy

## Interventions

- **DRUG:** Intralipid 20%
- **DRUG:** SMOFlipid 20%

## Key facts

- **NCT ID:** NCT00793195
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2012-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793195, "Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00793195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*